Design Therapeutics (DSGN) Stock Forecast
Analyst ratings, price targets, and earnings estimates.
DSGN Analyst Ratings
Hold
Consensus
Based on 5 analysts in the past 3 months
DSGN Stock 12 Month Forecast
$12.00
▲
(209.28%
Upside)
Highest Price Target
$42.00
(982.5%)
Average Price Target
$12.00
(209.3%)
Lowest Price Target
$7.00
(80.4%)
Based on 1 analysts in the last year
Recent Price Targets
Recommendation Trends
Analyst Estimates
Revenue Estimates
High
$50.12M
Average
$48.53M
Low
$46.94M
3 analysts
Net Income Estimates
High
$-60.86M
Average
$-67.06M
Low
$-75.49M
3 analysts
EPS Estimates
High
$-1.08
Average
$-1.21
Low
$-1.33
2 analysts
Revenue Estimates
High
$117.33M
Average
$117.33M
Low
$117.33M
3 analysts
Net Income Estimates
High
$-44.14M
Average
$-59.98M
Low
$-75.83M
3 analysts
EPS Estimates
High
$-0.78
Average
$-1.12
Low
$-1.34
2 analysts
Revenue Estimates
High
$204.78M
Average
$204.78M
Low
$204.78M
2 analysts
Net Income Estimates
High
$-74.13M
Average
$-74.13M
Low
$-74.13M
2 analysts
EPS Estimates
High
$-1.31
Average
$-1.31
Low
$-1.31
1 analysts
Revenue Estimates
High
$10.00M
Average
$10.00M
Low
$10.00M
1 analysts
Net Income Estimates
High
$-94.22M
Average
$-94.22M
Low
$-94.22M
1 analysts
EPS Estimates
High
$-1.67
Average
$-1.67
Low
$-1.67
1 analysts
Revenue Estimates
High
$54.00M
Average
$54.00M
Low
$54.00M
1 analysts
Net Income Estimates
High
$-73.00M
Average
$-73.00M
Low
$-73.00M
1 analysts
EPS Estimates
High
$-1.29
Average
$-1.29
Low
$-1.29
1 analysts
Latest Price Target Updates
Date | Analyst | Firm | Price Target | Price When Posted | Upside |
---|---|---|---|---|---|
May 07, 2024 | Yasmeen Rahimi | Piper Sandler | $12.00 | $3.65 | 228.8% |
Aug 15, 2023 | Leonid Timashev | RBC Capital | $7.00 | $2.17 | 223.3% |
Dec 07, 2022 | Yasmeen Rahimi | Piper Sandler | $42.00 | $12.69 | 231.0% |
May 02, 2022 | None | RBC Capital | $30.00 | $11.94 | 151.3% |
Jan 19, 2022 | Madhu Kumar | Goldman Sachs | $10.00 | $13.98 | 0.0% |
Related Metrics
Explore detailed financial metrics and analysis for DSGN.